Navigation Links
New Drug Promises Prolonged Survival in Prostate Cancer Patients

A new anti-cancer drug called pertuzumab, shows promise in slowing progression and prolonging survival time in men with prostate cancer.//

A new class of targeted anti-cancer drugs that blocks the human epidermal growth factor (HER) receptor family shows promise in prolonging the lives of patients with recurrent prostate cancer, a new Cedars-Sinai study shows. The drug, a molecular targeted compound called pertuzumab, works by binding to and inhibiting the function of HER2 receptors, interrupting a key pathway that leads to cancer growth.

The study, published in the February 20 issue of the Journal of Clinical Oncology, involved 41 patients with treatment-resistant prostate cancer who had experienced progression of their disease after prior chemotherapy. Patients received the drug every three weeks until disease progression. MRI and CAT scans were used to evaluate the tumors during the period of drug therapy. While no shrinkage of tumors was reported, retrospective analysis showed that survival rate was prolonged to 16.4 months with the drug as compared to a median average of 10.7 months in a historical control group with similar baseline prognostic features.

“Advanced prostate cancer is difficult to treat – and the drug therapies currently available to these patients have not been very effective, especially in patients whose disease has progressed after chemotherapy treatment,” said David B. Agus, M.D., principal investigator of the study and research director of Cedars-Sinai’s Louis Warschaw Prostate Cancer Center at the Samuel Oschin Comprehensive Cancer Institute. “Pertuzumab may offer a new treatment approach for these patients when it is evaluated as a tool to slow – not stop or shrink -- tumor growth.”

“The theory is that by significantly slowing progression of the cancer, patients will experience a good quality of life for a longer period of time,” said Agus. “Ultimately, we hope drugs like pertuzumab will help
'"/>




Page: 1 2 3

Related medicine news :

1. Marijuana-Derived Drug Promises Hope In Treating Bladder Infection
2. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
3. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
4. Maternal Vitamin D Supplementation Promises Healthy Bones In Child
5. Raw Vegan Diet Promises Lightweight, Healthy Bones
6. Stem Cell Transplantation Promises Cure for Type 2 Diabetes
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. Health Minister Promises Strict Quality Control On Herbal Medicines
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Nanotechnology Promises Huge Medical Benefits
11. Health Minister Promises New Benchmark for Wait Times
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Drug Promises Prolonged Survival Prostate Cancer Patients

(Date:6/3/2015)... Loma Linda University Health and Adventist Health ... Memorial Hospital (SGMH). The SGMH board voted unanimously to ... “Loma Linda University Health has been serving the Pass ... officer, Loma Linda University Medical Center. “We are thrilled ... this community.” , Under the proposed affiliation, Loma ...
(Date:6/3/2015)... “ Harmony ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers how ... aspect of their life. , A common mistake people make ... in their life. However, hypnotherapy is intended for anyone who ...
(Date:6/3/2015)... BC (PRWEB) June 03, 2015 Vancouver ... announced that the firm will now handle personal injury ... Greater Vancouver on the rise, more and more people ... year bus accidents cause needless suffering, serious injury and ... a result of a bus accident in BC you ...
(Date:6/3/2015)... York, NY (PRWEB) June 03, 2015 ... strategic partnership to expand online and mobile access ... Board Review and Maintenance of Certification (MOC) activities. ... will market VeoMed’s innovative courses to Decker’s extensive ... professionals interested in purchasing access to VeoMed’s premier ...
(Date:6/3/2015)... Visual BI Solutions, a leader in ... launch of the second release of its successful ... Studio. The Design Studio EXtension suite allows customers ... into their dashboarding projects. , With the second ... adding key components for customers that are looking ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3
... Alan Mozes HealthDay Reporter , TUESDAY, May 15 ... silver bullet when it comes to symptom relief for acute ... of six prior studies found that the sprays confer only ... for three weeks at relatively high doses. The disappointing ...
... May 15 (HealthDay News) -- Should Americans be able to buy ... they,re infected with the virus that causes AIDS? , , A ... question Tuesday, and the answer the panel arrives at could pave ... advisory panel recommendations are not binding, but they are often followed ...
... KNOX, Ky., May 15, 2012 The U.S. Army Medical ... to Mastership in the American College of Physicians (MACP). Only ... eminence through their contributions to the field of internal medicine ... or volunteerism, were awarded a Mastership in 2012. One of ...
... Child,s Age and Severity of Gait Abnormality ,Most ... 2. And while some toe walkingwhere a child primarily walks ... the heel to the groundis common, persistent toe walking beyond ... article, "Idiopathic Toe Walking," outlines the appropriate steps for effectively ...
... Center at HakensackUMC, one of the nation,s top 50 cancer ... year,s program, titled New Horizons in Neuro-Oncology- Innovations in the ... the most important advancements and innovations for the treatment of ... on Friday, May 18 from 8:00am to 1:00pm. ...
... a way to save money while having little effect on ... study. Researchers say that 57.6 percent of patients ... schizophrenia or bipolar disorder, the conditions for which the drugs ... is not FDA-approved is called off-label use. "Given ...
Cached Medicine News:Health News:Steroid Nasal Sprays Show Small Benefit for Sinusitis: Study 2Health News:Steroid Nasal Sprays Show Small Benefit for Sinusitis: Study 3Health News:FDA Panel to Consider At-Home HIV Test 2Health News:FDA Panel to Consider At-Home HIV Test 3Health News:US Army internal medicine Masters, Fellows honored by American College of Physicians 2Health News:US Army internal medicine Masters, Fellows honored by American College of Physicians 3Health News:US Army internal medicine Masters, Fellows honored by American College of Physicians 4Health News:Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights 2Health News:John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium 2Health News:Reducing off-label use of antipsychotic medications may save money 2Health News:Reducing off-label use of antipsychotic medications may save money 3
(Date:6/3/2015)... -- Research and Markets  ( http://www.researchandmarkets.com/research/rf4hfn/global ) has ... Diseases Market 2015-2019" report to their offering. ... grow at a CAGR of 4.77% over the ... present scenario and the growth prospects of the ... To calculate the market size, the report considers ...
(Date:6/3/2015)... BOSTON , June 3, 2015 PillPack, ... has completed a $50 million round of financing led ... Menlo Ventures, and Sherpa Ventures. The capital will be ... world-class team, and build retail pharmacies in US markets. ... and launched a better, simpler pharmacy experience that folks ...
(Date:6/3/2015)... June 3, 2015  Armetheon, Inc., a specialty ... cardiovascular diseases, today announced that Sanjay Kakkar ... Executive Officer, effective immediately. Dr. Kakkar brings more ... enterprises, with a successful track record in advancing ... With expertise that includes the development of novel ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... 2007--Treatment data from,Synovate Healthcare’s European Oncology Monitor reveals ... could become eligible,for a breast cancer treatment showing ... subject of a recent study detailed,in the online ... rates were shown in patients who had switched ...
... Findings Show Survival Improvement with Lower Doses ... and other,Drugs in Newly Diagnosed Myeloma -, ... -- The,International Myeloma Foundation (IMF) - supporting ... myeloma patients,families, researchers and physicians - today ...
Cached Medicine Technology:Over 10,000 UK Breast Cancer Patients Could Become Eligible Within,the Next Year for a Breast Cancer Therapy Showing Increased,Survival Rates, Reveals Synovate Healthcare’s European,Oncology Monitor 2Over 10,000 UK Breast Cancer Patients Could Become Eligible Within,the Next Year for a Breast Cancer Therapy Showing Increased,Survival Rates, Reveals Synovate Healthcare’s European,Oncology Monitor 3The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3
These backbiters enable simple access to the anterior horn of the meniscus....
ACUFEX Loop Handle. Blunt nose basket punch enables flush contouring of meniscus....
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
Medicine Products: